abstract |
PDE4 INHIBITION METHOD, PDE4 MEDIATED TREATMENT METHOD, COMPOUND AND PHARMACEUTICAL COMPOSITION. The present invention relates to compounds and methods that may be useful as inhibitors of phosphodiesterase 4 (PDE4) for the treatment or prevention of inflammatory diseases and other diseases involving high levels of cytokines and pro-inflammatory mediators. |